BGF World Healthscience vs BNP Paribas China Equity

BGF World Healthscience vs BNP Paribas China Equity

1. BGF World Healthscience

  • Security

    BGF World Healthscience A2

  • Fee

    2.17%

  • ISIN

    LU0122379950

  • Holdings

    10

2. BNP Paribas China Equity

  • Security

    BNP Paribas China Equity Classic USD Cap

  • Fee

    2.23%

  • ISIN

    LU0823426308

  • Holdings

    17

Fund Holdings

We have information about 20 holdings in BGF World Healthscience, where the largest holding is UnitedHealth (8.2), followed by Eli Lilly (7.01) and Novo Nordisk (6.67). In comparison with BNP Paribas China Equity, we have 23 holdings where Tencent is the largest holding (9.45), followed by Alibaba Group Holding Ltd (9.07) and Xiaomi (6.25).

All Holdings

Here we compare the holdings in BGF World Healthscience and BNP Paribas China Equity.

BGF World Healthscience BNP Paribas China Equity
1. UnitedHealth Group Inc
USA
8.2 %
1. Tencent Holdings Ltd
China
9.45 %
2. Eli Lilly and Co
USA
7.01 %
2. Alibaba Group Holding Ltd
China
9.07 %
3. Novo Nordisk B
Denmark
6.67 %
3. Xiaomi
China
6.25 %
4. Merck & Co Inc
Germany
3.99 %
4. China Merchants Bank Class H
China
5.33 %
5. Boston Scientific Corp
3.67 %
5. Industrial and Commercial Bank of China Ltd Class H
China
4.38 %
6. AbbVie Inc
USA
3.61 %
6. Pop Mart International Group Ltd
China
4.12 %
7. Amgen Inc
USA
3.58 %
7. Trip.com Group Ltd
Singapore
2.96 %
8. Sanofi SA
France
3.05 %
8. NetEase ADR
China
2.92 %
9. Abbott Laboratories
USA
3.02 %
9. Ping An Insurance Co
China
2.6 %
10. AstraZeneca
Sweden UK
2.98 %
10. Meituan Class B
China
2.57 %
- 11. KE Holdings Inc ADR
China
2.13 %
- 12. Taiwan Semiconductor Manufacturing Company
Taiwan
1.91 %
- 13. China Yangtze Power Co Ltd Class A
China
1.66 %
- 14. Fuyao Glass Industry Group Co Ltd Class A
China
1.65 %
- 15. BYD Co Ltd Class H
China
1.57 %
- 16. Contemporary Amperex Technology Co Ltd Class A
China
1.51 %
- 17. Pinduoduo Inc
China
1.5 %

The list of fund holdings was last updated on July 25, 2025.